Anti-inflammatory potency of FR167653, a p38 mitogen-activated protein kinase inhibitor, in mouse models of acute inflammation

By Nishikori T.   Irie K.   Suganuma T.   Ozaki M.   Yoshioka T.  

European Journal of Pharmacology, Vol. 451, Iss. 3, 2002-09 ,pp. : 327-333

Elsevier

Access to resources Recommend Favorite

Involvement of p38 mitogen-activated protein kinase in PLL-AGE-induced cyclooxgenase-2 expression

By Lin C.-H.   Wu C.-H.   Thum W.-Y.   Ho Y.-S.   Lee H.-M.  

European Journal of Pharmacology, Vol. 438, Iss. 3, 2002-03 ,pp. : 143-152

Elsevier

Access to resources Recommend Favorite

p38 Mitogen-Activated Protein Kinase (MAPK) in Rheumatoid Arthritis

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-08 ,pp. : 867-874

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Activity Relationships of p38 Mitogen-Activated Protein Kinase Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 9, 2005-01 ,pp. : 857-868

Bentham Science Publishers

Access to resources Recommend Favorite

Lipoteichoic acid-induced cyclooxygenase-2 expression requires activations of p44/42 and p38 mitogen-activated protein kinase signal pathways

By Lin C.-H.   Kuan I.-H.   Wang C.-H.   Lee H.-M.   Lee W.-S.   Sheu J.-R.   Hsiao G.   Wu C.-H.   Kuo H.-P.  

European Journal of Pharmacology, Vol. 450, Iss. 1, 2002-08 ,pp. : 1-9

Elsevier

Access to resources Recommend Favorite